What is Vectorious?
Vectorious Medical Technologies is at the forefront of developing advanced medical devices aimed at revolutionizing the treatment and management of heart failure. The company's core innovation lies in its implantable sensing technologies, which are designed to deliver continuous, real-time data on cardiac function. This capability empowers healthcare providers to offer more proactive and personalized care strategies for patients managing chronic cardiovascular diseases, potentially improving patient outcomes and reducing hospitalizations.
How much funding has Vectorious raised?
Vectorious has raised a total of $5M across 1 funding round:
Private Equity
$5M
Private Equity (2015): $5M with participation from RAD BioMed and Global Cardiovascular Innovation Center
Key Investors in Vectorious
RAD BioMed
RAD Biomed is an investment firm focused on early-stage digital health and medical device ventures, particularly those offering disruptive solutions. They provide strategic support and leverage their expertise to foster long-term growth for their portfolio companies.
Global Cardiovascular Innovation Center
The Global Cardiovascular Innovation Center is dedicated to advancing cardiovascular health through innovation and investment in cutting-edge technologies and research.
What's next for Vectorious?
With a major enterprise-level funding context and a recent strategic investment, Vectorious is poised for significant scaling and further development of its groundbreaking technologies. The substantial capital infusion is expected to accelerate product development, expand clinical trials, and facilitate market penetration. The company's focus on real-time cardiac monitoring positions it to capture a growing share of the digital health and medical device market, particularly within the critical area of cardiovascular care. Future growth will likely involve strategic partnerships and broader commercialization efforts.
See full Vectorious company page
